{"id":350,"date":"2015-07-07T07:32:08","date_gmt":"2015-07-07T07:32:08","guid":{"rendered":"http:\/\/www.glucotab.at\/?p=350&#038;lang=de"},"modified":"2016-07-21T07:45:55","modified_gmt":"2016-07-21T07:45:55","slug":"standardized-glycemic-management-with-a-computerized-workflow-and-decision-support-system-for-hospitalized-patients-with-type-2-diabetes-at-different-wards","status":"publish","type":"post","link":"https:\/\/www.glucotab.at\/de\/standardized-glycemic-management-with-a-computerized-workflow-and-decision-support-system-for-hospitalized-patients-with-type-2-diabetes-at-different-wards\/","title":{"rendered":"Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes at Different Wards"},"content":{"rendered":"<p>Diabetes Technology &amp; Therapeutics 17(10):000-000, 2015.<br \/>\n<a href=\"http:\/\/online.liebertpub.com\/doi\/pdfplus\/10.1089\/dia.2015.0027\">http:\/\/online.liebertpub.com\/doi\/pdfplus\/10.1089\/dia.2015.0027<\/a><\/p>\n<p><!--more--><\/p>\n<p>Klinische Evaluierung von GlucoTab\u00ae mit 99 PatientInnen an 4 Abteilungen des LKH Graz:<\/p>\n<p><strong><em>Wirksamkeit: <\/em><\/strong>72,5% aller BZ-Messungen lagen innerhalb des Zielbereichs. Dieses Ergebnis ist der Standardversorgung deutlich \u00fcberlegen und gleichwertig mit aktuellen best-practice Studien.<\/p>\n<p><strong><em>Sicherheit:<\/em><\/strong> Im Vergleich mit aktuellen Studien zu vergleichbaren Therapien ist das Risiko f\u00fcr Unterzuckerungen nicht erh\u00f6ht (keine schweren, nur 1,8% der BZ-Werte leichte Unterzuckerungen &lt;70 mg\/dl).<\/p>\n<p><strong><em>Akzeptanz:<\/em><\/strong> &gt;95% der vorgesehenen Arbeitsschritte wurden vom Personal mit dem System durchgef\u00fchrt und die vorgeschlagenen Insulindosen wurden zu &gt;95% angenommen.<\/p>\n<p><strong>Autoren:\u00a0<\/strong>Neubauer K, Mader J, Hoell B, Aberer F, Donsa K, Augustin T, Schaupp L, Spat S, Beck P, Fruhwald F, Schnedl C, Rosenkranz A, Lumenta D, Kamolz L, Plank J, Pieber TR:<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Diabetes Technology &amp; Therapeutics 17(10):000-000, 2015. http:\/\/online.liebertpub.com\/doi\/pdfplus\/10.1089\/dia.2015.0027<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-350","post","type-post","status-publish","format-standard","hentry","category-publikationen"],"_links":{"self":[{"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/posts\/350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/comments?post=350"}],"version-history":[{"count":2,"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/posts\/350\/revisions"}],"predecessor-version":[{"id":510,"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/posts\/350\/revisions\/510"}],"wp:attachment":[{"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/media?parent=350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/categories?post=350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.glucotab.at\/de\/wp-json\/wp\/v2\/tags?post=350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}